Shi, Liuming
Ning, Yijie
Wang, Qian
Fang, Yalan
Yao, Tian
Zhang, Jie
Zheng, Kefangyuan
Yan, Sheng
Li, Haifeng
Shi, Yongbin
Zhang, Ruijing
Wang, Guiming
Dong, Honglin
Funding for this research was provided by:
Shanxi Provincial Youth Scientific Research Project (Grant No.202403021212234)
Regional Cooperation Program of Shanxi Province, China (Grant No. 202204041101038)
Leading Talent Team Building Program of Shanxi Province, China (Grant No. 202204051002010)
Construction and demonstration of molecular diagnosis and treatment platform for vascular diseases in Shanxi Province, China (Grant No. SCP-2023-17)
Translational Medicine Engineering Research Center for Vascular Diseases of Shanxi Province, China (Grant No. 2022017)
Shanxi Provincial Science and Technology Department Centralized Guided Local Projects (Grant No. YDZJSX2021C026)
National Natural Science Foundation of China (Grant No. 82400883, 81770695, 81870354)
Article History
Received: 15 January 2026
Revised: 18 March 2026
Accepted: 17 April 2026
First Online: 29 April 2026
Declarations
:
: This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki (2013 revision) and followed the recommendations of the International Committee of Medical Journal Editors. The study protocol was reviewed and approved by the Ethics Committee of The Second Hospital of Shanxi Medical University (Approval No.: [2025] YX No. 023). Written informed consent was obtained from all participants prior to enrollment. Patient confidentiality and data privacy were strictly maintained, and all analyses were performed using anonymized datasets.
: The authors report there are no competing interests to declare.
: The authors declare no competing interests.